PetPace, a leading pet health monitoring company, has completed development of its smart collar and is preparing for mass production. The company expects to sell tens of thousands of collars in 2024 and has placed an initial manufacturing order of 10,000 units with Nistec, a well-established manufacturing group.
TechTime Electronics and Technology News translated to English // November 9, 2023
Production will take place at Nistec’s Ma’alot facility and will include electronic circuit assembly, electrical testing and the mechanical assembly of the strap to deliver a finished wearable product. To ensure the device can withstand the demands of continuous wear on animals, Nistec has implemented specialized production techniques such as laser welding and selected specific materials and adhesives engineered for durable, reliable performance in varied environmental conditions.
The smart collar is designed to provide continuous monitoring of a pet’s health and location, transmitting collected data via cellular networks and Wi‑Fi. PetPace’s President and General Manager, Lior Abraham, highlighted the product’s role in revealing hidden signs of ill health:
“Pets, like cats and dogs, instinctively hide weakness, pain, and illnesses. The smart collar allows for the identification of symptoms that require attention.”
Founded in 2012 by Avner Schneur, Avi Menkes and Dr. Asaf Dagan, the company operates with a compact team of approximately 20 employees focused on combining hardware, firmware and data analytics to support veterinary and pet owner needs. The collar continuously captures a range of physiological metrics: pulse, respiration, body temperature, heart rate variability (HRV), overall activity levels and posture, the latter obtained via onboard accelerometers. These measurements are transmitted to a companion mobile app and an online interface using Wi‑Fi and an embedded eSIM, while an integrated GPS module aids in locating pets both indoors and outdoors if they become lost.
One notable engineering achievement is the device’s power efficiency. Weighing only 45 grams, the collar is engineered to operate continuously for up to 40 days between charges, supporting long-term monitoring without frequent recharging. The combination of light weight, extended battery life and multi-network communications is intended to provide practical daily use for pet owners and continuous data for veterinarians.
Next Stage: Early Disease Detection
Abraham explained that the team has moved from development into resolving unforeseen technical challenges that arise when monitoring diverse animals. Accurate capture and interpretation of physiological signals can be difficult, particularly when sensors must work through fur or on hairless breeds. To address this, the company developed a patented method that compares multiple metrics to determine meaningful changes in temperature and other indicators, improving accuracy across different coat types.
“The main challenge is accurately capturing and interpreting physiological metrics, especially in animals with fur or without. For example, measuring the temperature of a furry or hairless pet. We addressed this issue through a patented solution that allows us to compare different metrics and determine whether there is an increase or decrease in temperature. The detection of pain, discomfort, or diseases presents another unique challenge, where artificial intelligence comes into play. We developed models that can identify conditions such as epilepsy, heatstroke, and have plans for detecting other diseases, including cancer.”
Artificial intelligence and pattern recognition models play a central role in translating raw sensor data into actionable alerts and early-warning signals. The company has already trained and validated models for detecting specific acute conditions such as seizures and heatstroke, and it intends to expand its diagnostic capabilities over time to include a broader set of health concerns.
PetPace has begun initial sales of its second‑generation product in the United States and plans staged expansion into Canada and Europe. Abraham stated that the company has received orders consistent with its production ramp-up and remains confident in the near-term demand forecast.
“We already have existing orders, and according to our projections, we will reach sales of several tens of thousands of units by 2024.”
For customers interested in the latest generation of the device, the company provides purchase options via its product page. The combination of continuous physiological monitoring, location tracking and AI-driven analysis aims to give pet owners and veterinarians earlier insight into health issues, potentially improving outcomes through timely intervention.
Shop for the PetPace Health 2.0 Here